Dr Fred Birnbaum, DPM | |
1950 Street Rd, Suite 101, Bensalem, PA 19020-3755 | |
(215) 245-0873 | |
(215) 245-4011 |
Full Name | Dr Fred Birnbaum |
---|---|
Gender | Male |
Speciality | Podiatry |
Experience | 46 Years |
Location | 1950 Street Rd, Bensalem, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053308478 | NPI | - | NPPES |
0844935 | Medicaid | PA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
213E00000X | Podiatrist | SC001969L (Pennsylvania) | Primary |
213ES0131X | Podiatrist - Foot Surgery | SC001969L (Pennsylvania) | Secondary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Bensalem Podiatry Assoc. | 3971544693 | 2 |
News Archive
New research from Ipsos MORI indicates that 18 per cent of the population of England and Wales believe their teeth would benefit from straightening with braces. Meanwhile, anecdotal evidence from orthodontists shows that people are prepared to make financial sacrifices to have treatment and see it as a valuable investment.
A statistical method could fill the gaps in the U.S. cancer registry data to estimate the short- and long-term risk of recurrence of hormone receptor (HR)-positive and HR-negative breast cancers.
VOA News examines malaria in southern Sudan. In the region, malaria is "widespread" and accounts for "up to 30 percent of all diseases treated by health facilities." It is the "number one killer of children in southern Sudan," though there are "no reliable statistics on the number in southern Sudan who suffer, or die from, malaria," VOA News reports.
Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs called ImmTACs to treat cancer and viral disease, today announced it has entered into a partnership with GlaxoSmithKline (GSK) for multiple novel targets not addressable using antibody-based technologies. This is Immunocore's second major partnership this year.
› Verified 5 days ago
Provider Name | Bensalem Podiatry Assoc. |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1467490169 PECOS PAC ID: 3971544693 Enrollment ID: O20050512000640 |
News Archive
New research from Ipsos MORI indicates that 18 per cent of the population of England and Wales believe their teeth would benefit from straightening with braces. Meanwhile, anecdotal evidence from orthodontists shows that people are prepared to make financial sacrifices to have treatment and see it as a valuable investment.
A statistical method could fill the gaps in the U.S. cancer registry data to estimate the short- and long-term risk of recurrence of hormone receptor (HR)-positive and HR-negative breast cancers.
VOA News examines malaria in southern Sudan. In the region, malaria is "widespread" and accounts for "up to 30 percent of all diseases treated by health facilities." It is the "number one killer of children in southern Sudan," though there are "no reliable statistics on the number in southern Sudan who suffer, or die from, malaria," VOA News reports.
Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs called ImmTACs to treat cancer and viral disease, today announced it has entered into a partnership with GlaxoSmithKline (GSK) for multiple novel targets not addressable using antibody-based technologies. This is Immunocore's second major partnership this year.
› Verified 5 days ago
Provider Name | Dpmscollprpa Llc |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1063601623 PECOS PAC ID: 3173611746 Enrollment ID: O20071207000160 |
News Archive
New research from Ipsos MORI indicates that 18 per cent of the population of England and Wales believe their teeth would benefit from straightening with braces. Meanwhile, anecdotal evidence from orthodontists shows that people are prepared to make financial sacrifices to have treatment and see it as a valuable investment.
A statistical method could fill the gaps in the U.S. cancer registry data to estimate the short- and long-term risk of recurrence of hormone receptor (HR)-positive and HR-negative breast cancers.
VOA News examines malaria in southern Sudan. In the region, malaria is "widespread" and accounts for "up to 30 percent of all diseases treated by health facilities." It is the "number one killer of children in southern Sudan," though there are "no reliable statistics on the number in southern Sudan who suffer, or die from, malaria," VOA News reports.
Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs called ImmTACs to treat cancer and viral disease, today announced it has entered into a partnership with GlaxoSmithKline (GSK) for multiple novel targets not addressable using antibody-based technologies. This is Immunocore's second major partnership this year.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Fred Birnbaum, DPM 1950 Street Rd, Suite 101, Bensalem, PA 19020-3755 Ph: (215) 245-0873 | Dr Fred Birnbaum, DPM 1950 Street Rd, Suite 101, Bensalem, PA 19020-3755 Ph: (215) 245-0873 |
News Archive
New research from Ipsos MORI indicates that 18 per cent of the population of England and Wales believe their teeth would benefit from straightening with braces. Meanwhile, anecdotal evidence from orthodontists shows that people are prepared to make financial sacrifices to have treatment and see it as a valuable investment.
A statistical method could fill the gaps in the U.S. cancer registry data to estimate the short- and long-term risk of recurrence of hormone receptor (HR)-positive and HR-negative breast cancers.
VOA News examines malaria in southern Sudan. In the region, malaria is "widespread" and accounts for "up to 30 percent of all diseases treated by health facilities." It is the "number one killer of children in southern Sudan," though there are "no reliable statistics on the number in southern Sudan who suffer, or die from, malaria," VOA News reports.
Immunocore Limited, the Oxford-based biotechnology company developing novel biological drugs called ImmTACs to treat cancer and viral disease, today announced it has entered into a partnership with GlaxoSmithKline (GSK) for multiple novel targets not addressable using antibody-based technologies. This is Immunocore's second major partnership this year.
› Verified 5 days ago
Dr. Angelo Paul Savelloni, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3554 Hulmeville Rd Ste 104, Bensalem, PA 19020 Phone: 215-245-1818 Fax: 215-245-9129 | |
Foot And Ankle Center Inc Podiatrist Medicare: Medicare Enrolled Practice Location: 2222 Bristol Pike, Bensalem, PA 19020 Phone: 215-638-3338 Fax: 215-638-3030 | |
Grace Anne Kuzara, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 3200 Bensalem Blvd, Bensalem, PA 19020 Phone: 856-241-0747 Fax: 856-423-0823 | |
Foot And Ankle Center, Inc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2222 Bristol Pike, Bensalem, PA 19020 Phone: 215-638-3338 Fax: 215-638-3030 | |
Dr. Jerry D Simms, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 2404 Bristol Rd, Bensalem, PA 19020 Phone: 215-752-1881 Fax: 215-752-6907 | |
Dr. Erigena Baze, DPM Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 2222 Bristol Pike, Bensalem, PA 19020 Phone: 215-245-1818 Fax: 215-245-9129 |